Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating cancer by conjunctive therapy with N,N.sup.1 -bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent

US Patent 5654287 · Granted Aug 5, 1997

Assignee

Inventors

View full patent text on Google Patents →